Eli Income Statement Research

LLY Stock  USD 778.18  3.28  0.42%   
Most accounts from Eli Lilly's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Eli Lilly And current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Eli Lilly Valuation and Eli Lilly Correlation analysis.
  
At this time, Eli Lilly's Discontinued Operations is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 1.6 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 994.5 M in 2024.
Most accounts from Eli Lilly's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Eli Lilly And current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Eli Lilly Valuation and Eli Lilly Correlation analysis.
At this time, Eli Lilly's Discontinued Operations is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 1.6 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 994.5 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit21.0B21.9B27.5B28.9B
Total Revenue28.3B28.5B34.1B35.8B

Eli Lilly income statement Correlations

0.670.580.520.840.320.310.430.920.540.670.080.640.110.660.490.150.08-0.23-0.410.180.090.55-0.370.37-0.2
0.670.750.740.580.690.710.760.590.680.66-0.180.640.090.390.750.410.0-0.46-0.710.330.290.67-0.850.83-0.54
0.580.751.00.710.870.840.890.660.980.62-0.510.540.290.640.980.2-0.12-0.34-0.720.160.310.5-0.620.660.0
0.520.741.00.680.910.860.890.60.980.62-0.520.540.280.620.980.23-0.15-0.32-0.710.170.290.47-0.630.67-0.01
0.840.580.710.680.440.420.50.950.730.72-0.140.610.370.850.630.030.02-0.09-0.370.050.230.34-0.290.31-0.15
0.320.690.870.910.440.90.90.340.820.62-0.510.60.050.330.90.49-0.28-0.41-0.780.330.110.49-0.730.76-0.01
0.310.710.840.860.420.90.990.370.770.4-0.740.340.240.270.860.260.09-0.49-0.750.470.450.55-0.660.690.04
0.430.760.890.890.50.90.990.470.810.47-0.690.40.230.350.890.270.09-0.5-0.770.470.430.59-0.680.710.02
0.920.590.660.60.950.340.370.470.640.63-0.110.540.320.740.580.020.07-0.26-0.440.050.30.51-0.310.33-0.11
0.540.680.980.980.730.820.770.810.640.58-0.490.490.320.740.950.08-0.11-0.2-0.590.10.270.36-0.510.550.03
0.670.660.620.620.720.620.40.470.630.580.220.960.10.570.570.58-0.4-0.15-0.540.03-0.090.51-0.60.58-0.43
0.08-0.18-0.51-0.52-0.14-0.51-0.74-0.69-0.11-0.490.220.3-0.33-0.07-0.550.24-0.360.30.33-0.36-0.56-0.080.14-0.21-0.45
0.640.640.540.540.610.60.340.40.540.490.960.3-0.180.450.50.71-0.51-0.19-0.550.09-0.30.49-0.630.6-0.43
0.110.090.290.280.370.050.240.230.320.320.1-0.33-0.180.410.23-0.470.430.150.05-0.170.790.050.14-0.090.04
0.660.390.640.620.850.330.270.350.740.740.57-0.070.450.410.51-0.220.060.32-0.05-0.040.080.02-0.010.02-0.02
0.490.750.980.980.630.90.860.890.580.950.57-0.550.50.230.510.26-0.18-0.46-0.790.160.320.52-0.690.74-0.01
0.150.410.20.230.030.490.260.270.020.080.580.240.71-0.47-0.220.26-0.7-0.4-0.620.07-0.360.52-0.710.69-0.38
0.080.0-0.12-0.150.02-0.280.090.090.07-0.11-0.4-0.36-0.510.430.06-0.18-0.70.10.330.510.53-0.090.37-0.380.15
-0.23-0.46-0.34-0.32-0.09-0.41-0.49-0.5-0.26-0.2-0.150.3-0.190.150.32-0.46-0.40.10.82-0.25-0.35-0.780.65-0.670.07
-0.41-0.71-0.72-0.71-0.37-0.78-0.75-0.77-0.44-0.59-0.540.33-0.550.05-0.05-0.79-0.620.330.82-0.2-0.27-0.850.87-0.90.15
0.180.330.160.170.050.330.470.470.050.10.03-0.360.09-0.17-0.040.160.070.51-0.25-0.20.040.29-0.140.10.14
0.090.290.310.290.230.110.450.430.30.27-0.09-0.56-0.30.790.080.32-0.360.53-0.35-0.270.040.33-0.160.2-0.05
0.550.670.50.470.340.490.550.590.510.360.51-0.080.490.050.020.520.52-0.09-0.78-0.850.290.33-0.710.7-0.19
-0.37-0.85-0.62-0.63-0.29-0.73-0.66-0.68-0.31-0.51-0.60.14-0.630.14-0.01-0.69-0.710.370.650.87-0.14-0.16-0.71-0.990.53
0.370.830.660.670.310.760.690.710.330.550.58-0.210.6-0.090.020.740.69-0.38-0.67-0.90.10.20.7-0.99-0.46
-0.2-0.540.0-0.01-0.15-0.010.040.02-0.110.03-0.43-0.45-0.430.04-0.02-0.01-0.380.150.070.150.14-0.05-0.190.53-0.46
Click cells to compare fundamentals

Eli Lilly Account Relationship Matchups

Eli Lilly income statement Accounts

201920202021202220232024 (projected)
Interest Expense400.6M359.6M339.8M331.6M312.3M327.9M
Total Revenue22.3B24.5B28.3B28.5B34.1B35.8B
Gross Profit17.6B19.1B21.0B21.9B27.5B28.9B
Operating Income5.0B6.1B6.4B7.1B10.3B10.8B
Ebit5.0B6.1B6.4B7.1B10.9B11.5B
Ebitda6.6B7.6B8.7B9.4B12.5B13.1B
Cost Of Revenue4.7B5.5B7.3B6.6B6.6B3.6B
Income Before Tax5.3B7.2B6.2B6.8B6.6B3.5B
Net Income4.6B6.2B5.6B6.2B5.2B2.7B
Income Tax Expense628M1.0B573.8M561.6M1.3B810.6M
Research Development5.6B6.1B7.0B7.2B9.3B9.8B
Non Recurring2.8B2.5B815.2M244.6M281.3M267.2M
Minority Interest75.7M1.1B92.2M183.6M211.1M241.8M
Tax Provision628M1.0B573.8M561.6M1.3B989.6M
Interest Income80.4M326.6M314.4M268.8M173.6M204.8M
Net Interest Income(320.2M)(326.6M)(314.4M)(268.8M)(312.3M)(327.9M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.13
Dividend Share
4.52
Earnings Share
5.81
Revenue Per Share
37.908
Quarterly Revenue Growth
0.281
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.